Wells Fargo & Company Atri Cure, Inc. Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Atri Cure, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 70,809 shares of ATRC stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,809

Previous 57,407 23.35%

Holding current value

$2.25 Million

Previous $1.75 Million 30.22%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$30.4 - $42.4 $407,420 - $568,244	13,402 Added 23.35%	70,809 $2.28 Million
Q4 2024 Feb 12, 2025	SELL	$27.02 - $38.2 $1.02 Million - $1.45 Million	-37,874 Reduced 39.75%	57,407 $1.75 Million
Q3 2024 Nov 13, 2024	SELL	$20.34 - $29.5 $1.1 Million - $1.59 Million	-53,871 Reduced 36.12%	95,281 $2.67 Million
Q2 2024 Aug 13, 2024	BUY	$19.86 - $29.09 $88,972 - $130,323	4,480 Added 3.1%	149,152 $3.4 Million
Q1 2024 May 10, 2024	SELL	$28.21 - $37.78 $234,114 - $313,536	-8,299 Reduced 5.43%	144,672 $4.4 Million
Q4 2023 Feb 09, 2024	BUY	$32.99 - $43.25 $1.24 Million - $1.62 Million	37,564 Added 32.55%	152,971 $5.46 Million
Q3 2023 Nov 13, 2023	SELL	$41.12 - $57.73 $394,587 - $553,977	-9,596 Reduced 7.68%	115,407 $5.05 Million
Q2 2023 Aug 15, 2023	BUY	$40.44 - $49.6 $325,137 - $398,784	8,040 Added 6.87%	125,003 $6.17 Million
Q1 2023 May 12, 2023	BUY	$35.87 - $47.22 $517,675 - $681,479	14,432 Added 14.08%	116,963 $4.85 Million
Q4 2022 Feb 13, 2023	BUY	$33.48 - $47.45 $575,655 - $815,855	17,194 Added 20.15%	102,531 $4.55 Million
Q3 2022 Nov 14, 2022	SELL	$38.25 - $52.62 $512,932 - $705,634	-13,410 Reduced 13.58%	85,337 $3.34 Million
Q2 2022 Aug 12, 2022	SELL	$35.1 - $66.01 $1.85 Million - $3.48 Million	-52,649 Reduced 34.78%	98,747 $4.04 Million
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $162,526 - $202,033	-2,830 Reduced 1.83%	151,396 $9.94 Million
Q4 2021 Feb 14, 2022	BUY	$63.4 - $87.14 $807,779 - $1.11 Million	12,741 Added 9.01%	154,226 $10.7 Million
Q3 2021 Nov 15, 2021	BUY	$69.28 - $84.46 $369,747 - $450,763	5,337 Added 3.92%	141,485 $9.84 Million
Q2 2021 Aug 16, 2021	SELL	$64.13 - $80.18 $1.89 Million - $2.37 Million	-29,522 Reduced 17.82%	136,148 $10.8 Million
Q1 2021 May 13, 2021	SELL	$53.79 - $66.98 $3 Million - $3.73 Million	-55,729 Reduced 25.17%	165,670 $10.9 Million
Q4 2020 Feb 09, 2021	BUY	$34.56 - $57.55 $1.63 Million - $2.71 Million	47,101 Added 27.02%	221,399 $12.3 Million
Q3 2020 Nov 05, 2020	BUY	$38.36 - $46.91 $305,000 - $372,981	7,951 Added 4.78%	174,298 $6.95 Million
Q2 2020 Aug 13, 2020	BUY	$31.78 - $51.19 $2.06 Million - $3.31 Million	64,689 Added 63.63%	166,347 $7.48 Million
Q1 2020 May 14, 2020	BUY	$24.49 - $43.84 $2.49 Million - $4.46 Million	101,658 New	101,658 $3.41 Million

Others Institutions Holding ATRC

# of Institutions

238

Shares Held

52M

Call Options Held

32.6K

Put Options Held

4.5K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.47B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Atri Cure, Inc. Transaction History